CO [China Cord Blood] 20-F: FORM 20-F o OR x OR o For

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]

By | 2016-08-02T11:40:07+00:00 July 28th, 2016|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

HNP [HUANENG POWER INTERNATIONAL] 6-K: This Form 6-K consists of: (a Sino-foreign joint

[This Form 6-K consists of: (a Sino-foreign joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 902) ANNOUNCEMENT ON COMPLETION OF IMPLEMENTATION OF INCREASE IN SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER Company Huaneng International Huaneng Group Increase in Shareholding The controlling shareholder of Huaneng Power International, Inc. (the “ Recently, the Company received a]

By | 2016-08-02T12:56:40+00:00 July 28th, 2016|Categories: Chinese Stocks, HNP, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 20-F: FORM 20-F o OR x OR o For

[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48 th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48 th Floor, Bank of China] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 28, 2016 Ting Zheng Chief Executive Officer July 28, 2016 Albert Chen Chief Financial Officer (Principal Financial Officer) EX-13.1 5 a16-7975_1ex13d1.htm EX-13.1] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our report dated July 31, 2015, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statements No. 333-183143 and No. 333-191121 on Form F-3 of China Cord Blood Corporation of our reports dated July 28, 2016, with respect to the consolidated balance sheet of China Cord Blood Corporation and subsidiaries as of March 31,] [Letter from Independent Registered Public Accounting Firm Ladies and Gentlemen: We were previously principal accountants for China Cord Blood Corporation and, under the date of July 31, 2015, we reported on the consolidated financial statements of China Cord Blood Corporation as of March 31, 2014 and 2015 and for each of the years in the three-year period ended March 31,]

By | 2016-08-02T11:40:56+00:00 July 28th, 2016|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

XIN [Xinyuan Real Estate] 6-K: (Original Filing)

[Xinyuan Real Estate Co., Ltd. Announces Management Change BEIJING, China, July 27, 2016 Mr. Zhang joins Xinyuan after working at Wanda Group, one of China's largest property enterprises, for nearly seven years with different positions. Since January 2014, Mr. Zhang served as General Manager at Wanda One UK Co., Ltd. From 2011 to 2013, Mr. Zhang worked as Assistant to] []

BIDU [Baidu] 6-K: (Original Filing)

[Baidu Announces Receipt of Withdrawal of Buyer Group’s Non-Binding Offer to Acquire Qiyi.com, Inc. BEIJING, July 25, 2016 – Baidu, Inc. (“Baidu”) (NASDAQ: BIDU), the leading Chinese language Internet search provider, today announced that the special committee of the Company’s board of directors received a letter from Mr. Robin Yanhong Li, chairman and chief executive officer of Baidu, and Mr.] [FORM 6-K BAIDU, INC. Baidu Campus No. 10 Shangdi 10th Street Haidian District, Beijing 100085 The People’s Republic of China x ¨ Form 20-F ¨ ¨ BAIDU, INC. By : : Jennifer Xinzhe Li : Chief Financial Officer 6-K 1 d233102d6k.htm FORM 6-K]

BIDU [Baidu] 6-K: Baidu Announces Receipt of Withdrawal of Buyer Group’s

[Baidu Announces Receipt of Withdrawal of Buyer Group’s Non-Binding Offer to Acquire Qiyi.com, Inc. BEIJING, July 25, 2016 – Baidu, Inc. (“Baidu”) (NASDAQ: BIDU), the leading Chinese language Internet search provider, today announced that the special committee of the Company’s board of directors received a letter from Mr. Robin Yanhong Li, chairman and chief executive officer of Baidu, and Mr.] [FORM 6-K BAIDU, INC. Baidu Campus No. 10 Shangdi 10th Street Haidian District, Beijing 100085 The People’s Republic of China x ¨ Form 20-F ¨ ¨ BAIDU, INC. By : : Jennifer Xinzhe Li : Chief Financial Officer 6-K 1 d233102d6k.htm FORM 6-K]

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: (Original Filing)

[News Release Contact: Siliconware Precision Industries Co., Ltd. No.45, Jieh Show Rd. Hsinchu Science Park, Hsinchu Taiwan, 30056 www.spil.com.tw Janet Chen, IR Director janet@spil.com.tw +886-3-5795678#3675 Mike Ma, Spokesperson mikema@spil.com.tw +886-4-25545527#5601 Siliconware Precision Industries Reports a 12.3% Quarter-over-Quarter growth in Revenues Resulting in Basic Earnings per Share of NT$ 0.90 or Diluted Earnings per Share of NT$ 0.78. Basic Earnings per]

By | 2016-07-28T02:21:41+00:00 July 27th, 2016|Categories: Chinese Stocks, SEC Original, SPIL|Tags: , , , , , |0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: News Release Contact: Siliconware Precision Industries Co., Ltd.

[News Release Contact: Siliconware Precision Industries Co., Ltd. No.45, Jieh Show Rd. Hsinchu Science Park, Hsinchu Taiwan, 30056 www.spil.com.tw Janet Chen, IR Director janet@spil.com.tw +886-3-5795678#3675 Mike Ma, Spokesperson mikema@spil.com.tw +886-4-25545527#5601 Siliconware Precision Industries Reports a 12.3% Quarter-over-Quarter growth in Revenues Resulting in Basic Earnings per Share of NT$ 0.90 or Diluted Earnings per Share of NT$ 0.78. Basic Earnings per]

By | 2016-07-28T02:22:42+00:00 July 27th, 2016|Categories: Chinese Stocks, SPIL, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar